HEADER OXIDOREDUCTASE 22-FEB-17 5UXF TITLE CRYSTAL STRUCTURE OF MOUSE RECON (AKR1C13) IN COMPLEX WITH CYCLIC DI- TITLE 2 AMP COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDRODIOL DEHYDROGENASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RECON; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: AKR1C13, DDH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PSPEEDET KEYWDS CYCLIC DI-AMP, ALDO-KETO REDUCTASE, TIM BARREL, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR S.LUO,L.TONG REVDAT 3 06-MAR-24 5UXF 1 COMPND HETNAM REVDAT 2 22-NOV-17 5UXF 1 REMARK REVDAT 1 19-APR-17 5UXF 0 JRNL AUTH A.P.MCFARLAND,S.LUO,F.AHMED-QADRI,M.ZUCK,E.F.THAYER,Y.A.GOO, JRNL AUTH 2 K.HYBISKE,L.TONG,J.J.WOODWARD JRNL TITL SENSING OF BACTERIAL CYCLIC DINUCLEOTIDES BY THE JRNL TITL 2 OXIDOREDUCTASE RECON PROMOTES NF-KAPPA B ACTIVATION AND JRNL TITL 3 SHAPES A PROINFLAMMATORY ANTIBACTERIAL STATE. JRNL REF IMMUNITY V. 46 433 2017 JRNL REFN ISSN 1097-4180 JRNL PMID 28329705 JRNL DOI 10.1016/J.IMMUNI.2017.02.014 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 51925 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.186 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2623 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.1852 - 4.0005 0.98 2770 148 0.1560 0.1532 REMARK 3 2 4.0005 - 3.1776 0.97 2620 140 0.1543 0.1575 REMARK 3 3 3.1776 - 2.7766 1.00 2677 143 0.1821 0.2154 REMARK 3 4 2.7766 - 2.5230 1.00 2637 140 0.1783 0.2109 REMARK 3 5 2.5230 - 2.3423 1.00 2660 142 0.1749 0.1885 REMARK 3 6 2.3423 - 2.2043 1.00 2625 137 0.1790 0.1805 REMARK 3 7 2.2043 - 2.0940 1.00 2613 139 0.1634 0.1895 REMARK 3 8 2.0940 - 2.0029 1.00 2628 140 0.1681 0.2145 REMARK 3 9 2.0029 - 1.9258 1.00 2614 139 0.1716 0.2260 REMARK 3 10 1.9258 - 1.8594 1.00 2623 140 0.1855 0.1990 REMARK 3 11 1.8594 - 1.8013 1.00 2574 137 0.1697 0.2044 REMARK 3 12 1.8013 - 1.7498 1.00 2633 140 0.1656 0.1869 REMARK 3 13 1.7498 - 1.7037 1.00 2611 139 0.1610 0.1535 REMARK 3 14 1.7037 - 1.6622 1.00 2602 138 0.1593 0.1846 REMARK 3 15 1.6622 - 1.6244 1.00 2600 138 0.1578 0.1745 REMARK 3 16 1.6244 - 1.5898 1.00 2616 140 0.1642 0.2110 REMARK 3 17 1.5898 - 1.5580 0.98 2537 134 0.1627 0.1985 REMARK 3 18 1.5580 - 1.5286 0.96 2459 132 0.1722 0.1945 REMARK 3 19 1.5286 - 1.5014 0.85 2203 117 0.1810 0.2042 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.120 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.06 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.22 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2631 REMARK 3 ANGLE : 0.977 3570 REMARK 3 CHIRALITY : 0.057 393 REMARK 3 PLANARITY : 0.006 454 REMARK 3 DIHEDRAL : 14.791 1600 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UXF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1000226587. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52009 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.24200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M NACL, 0.1 M BIS-TRIS, PH5.5, 25% REMARK 280 PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.32200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.20800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.71100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.20800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.32200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.71100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -18 REMARK 465 GLY A -17 REMARK 465 SER A -16 REMARK 465 ASP A -15 REMARK 465 LYS A -14 REMARK 465 ILE A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 GLU A -6 REMARK 465 ASN A -5 REMARK 465 LEU A -4 REMARK 465 TYR A -3 REMARK 465 GLN A 222 REMARK 465 ARG A 223 REMARK 465 TYR A 224 REMARK 465 LYS A 225 REMARK 465 GLU A 226 REMARK 465 TRP A 227 REMARK 465 VAL A 228 REMARK 465 ASP A 229 REMARK 465 GLN A 230 REMARK 465 ASN A 231 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 5 -60.97 -95.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 932 DISTANCE = 6.19 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 2BA A 401 DBREF 5UXF A 1 323 UNP Q54A37 Q54A37_MOUSE 1 323 SEQADV 5UXF MET A -18 UNP Q54A37 INITIATING METHIONINE SEQADV 5UXF GLY A -17 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF SER A -16 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF ASP A -15 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF LYS A -14 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF ILE A -13 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF HIS A -12 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF HIS A -11 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF HIS A -10 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF HIS A -9 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF HIS A -8 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF HIS A -7 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF GLU A -6 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF ASN A -5 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF LEU A -4 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF TYR A -3 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF PHE A -2 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF GLN A -1 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF GLY A 0 UNP Q54A37 EXPRESSION TAG SEQADV 5UXF ALA A 68 UNP Q54A37 LYS 68 ENGINEERED MUTATION SEQADV 5UXF ALA A 70 UNP Q54A37 LYS 70 ENGINEERED MUTATION SEQRES 1 A 342 MET GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS GLU SEQRES 2 A 342 ASN LEU TYR PHE GLN GLY MET SER SER LYS GLN HIS CYS SEQRES 3 A 342 VAL LYS LEU ASN ASP GLY HIS LEU ILE PRO ALA LEU GLY SEQRES 4 A 342 PHE GLY THR TYR LYS PRO LYS GLU VAL PRO LYS SER LYS SEQRES 5 A 342 SER LEU GLU ALA ALA CYS LEU ALA LEU ASP VAL GLY TYR SEQRES 6 A 342 ARG HIS VAL ASP THR ALA TYR ALA TYR GLN VAL GLU GLU SEQRES 7 A 342 GLU ILE GLY GLN ALA ILE GLN SER ALA ILE ALA ALA GLY SEQRES 8 A 342 VAL VAL LYS ARG GLU ASP LEU PHE VAL THR THR LYS LEU SEQRES 9 A 342 TRP CYS THR CYS PHE ARG PRO GLU LEU VAL LYS PRO ALA SEQRES 10 A 342 LEU GLU LYS SER LEU LYS LYS LEU GLN LEU ASP TYR VAL SEQRES 11 A 342 ASP LEU TYR ILE MET HIS TYR PRO VAL PRO MET LYS SER SEQRES 12 A 342 GLY ASP ASN ASP PHE PRO VAL ASN GLU GLN GLY LYS SER SEQRES 13 A 342 LEU LEU ASP THR VAL ASP PHE CYS ASP THR TRP GLU ARG SEQRES 14 A 342 LEU GLU GLU CYS LYS ASP ALA GLY LEU VAL LYS SER ILE SEQRES 15 A 342 GLY VAL SER ASN PHE ASN HIS ARG GLN LEU GLU ARG ILE SEQRES 16 A 342 LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO VAL CYS ASN SEQRES 17 A 342 GLN VAL GLU CYS HIS LEU TYR LEU ASN GLN ARG LYS LEU SEQRES 18 A 342 LEU ASP TYR CYS GLU SER LYS ASP ILE VAL LEU VAL ALA SEQRES 19 A 342 TYR GLY ALA LEU GLY THR GLN ARG TYR LYS GLU TRP VAL SEQRES 20 A 342 ASP GLN ASN SER PRO VAL LEU LEU ASN ASP PRO VAL LEU SEQRES 21 A 342 CYS ASP VAL ALA LYS LYS ASN LYS ARG SER PRO ALA LEU SEQRES 22 A 342 ILE ALA LEU ARG TYR LEU ILE GLN ARG GLY ILE VAL PRO SEQRES 23 A 342 LEU ALA GLN SER PHE LYS GLU ASN GLU MET ARG GLU ASN SEQRES 24 A 342 LEU GLN VAL PHE GLY PHE GLN LEU SER PRO GLU ASP MET SEQRES 25 A 342 LYS THR LEU ASP GLY LEU ASN LYS ASN PHE ARG TYR LEU SEQRES 26 A 342 PRO ALA GLU PHE LEU VAL ASP HIS PRO GLU TYR PRO PHE SEQRES 27 A 342 VAL GLU GLU TYR HET 2BA A 401 44 HETNAM 2BA (2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-2,9-BIS(6- HETNAM 2 2BA AMINO-9H-PURIN-9-YL)OCTAHYDRO-2H,7H-DIFURO[3,2-D:3', HETNAM 3 2BA 2'-J][1,3,7,9,2,8 ]TETRAOXADIPHOSPHACYCLODODECINE-3,5, HETNAM 4 2BA 10,12-TETROL 5,12-DIOXIDE HETSYN 2BA BIS-(3',5')-CYCLIC-DIMERIC-ADENOSINE-MONOPHOSPHATE FORMUL 2 2BA C20 H24 N10 O12 P2 FORMUL 3 HOH *432(H2 O) HELIX 1 AA1 PRO A 30 GLY A 45 1 16 HELIX 2 AA2 ALA A 52 GLN A 56 5 5 HELIX 3 AA3 VAL A 57 ALA A 71 1 15 HELIX 4 AA4 LYS A 75 LEU A 79 5 5 HELIX 5 AA5 TRP A 86 PHE A 90 5 5 HELIX 6 AA6 ARG A 91 GLU A 93 5 3 HELIX 7 AA7 LEU A 94 GLN A 107 1 14 HELIX 8 AA8 ASP A 143 ALA A 157 1 15 HELIX 9 AA9 ASN A 169 ASN A 178 1 10 HELIX 10 AB1 GLN A 199 LYS A 209 1 11 HELIX 11 AB2 VAL A 234 ASN A 237 5 4 HELIX 12 AB3 ASP A 238 LYS A 249 1 12 HELIX 13 AB4 SER A 251 ARG A 263 1 13 HELIX 14 AB5 LYS A 273 LEU A 281 1 9 HELIX 15 AB6 GLN A 282 PHE A 286 5 5 HELIX 16 AB7 SER A 289 GLY A 298 1 10 HELIX 17 AB8 ALA A 308 VAL A 312 5 5 SHEET 1 AA1 2 CYS A 7 LYS A 9 0 SHEET 2 AA1 2 LEU A 15 PRO A 17 -1 O ILE A 16 N VAL A 8 SHEET 1 AA2 9 GLY A 20 GLY A 22 0 SHEET 2 AA2 9 HIS A 48 ASP A 50 1 O ASP A 50 N PHE A 21 SHEET 3 AA2 9 PHE A 80 LEU A 85 1 O PHE A 80 N VAL A 49 SHEET 4 AA2 9 VAL A 111 MET A 116 1 O ILE A 115 N LEU A 85 SHEET 5 AA2 9 VAL A 160 SER A 166 1 O LYS A 161 N VAL A 111 SHEET 6 AA2 9 CYS A 188 GLU A 192 1 O GLN A 190 N VAL A 165 SHEET 7 AA2 9 VAL A 212 TYR A 216 1 O VAL A 214 N VAL A 191 SHEET 8 AA2 9 VAL A 266 ALA A 269 1 O LEU A 268 N ALA A 215 SHEET 9 AA2 9 GLY A 20 GLY A 22 1 N GLY A 20 O ALA A 269 SITE 1 AC1 25 TYR A 24 TYR A 55 TYR A 216 GLY A 217 SITE 2 AC1 25 ALA A 218 LEU A 219 GLY A 220 THR A 221 SITE 3 AC1 25 ALA A 253 GLN A 270 SER A 271 GLU A 276 SITE 4 AC1 25 GLU A 279 ASN A 280 HOH A 506 HOH A 536 SITE 5 AC1 25 HOH A 538 HOH A 539 HOH A 547 HOH A 552 SITE 6 AC1 25 HOH A 554 HOH A 608 HOH A 643 HOH A 660 SITE 7 AC1 25 HOH A 771 CRYST1 48.644 75.422 88.416 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020558 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013259 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011310 0.00000